Literature DB >> 25796427

CEUS of the pancreas: Still research or the standard of care.

Mirko D'Onofrio1, Stefano Canestrini2, Riccardo De Robertis2, Stefano Crosara2, Emanuele Demozzi2, Valentina Ciaravino2, Roberto Pozzi Mucelli2.   

Abstract

Contrast-enhanced ultrasonography (CEUS) improves the characterization of pancreatic masses. CEUS is in fact a safe and accurate imaging method to evaluate the vascularity of pancreatic lesions. CEUS should be performed when possible immediately after the ultrasound (US) detection of a pancreatic mass. CEUS is accurate in the characterization of ductal adenocarcinoma. The use of CEUS in studying pancreatic lesions found at US, especially in the same session of ultrasound examination, is therefore recommendable to promote faster diagnosis mainly of pancreatic ductal adenocarcinoma.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CEUS; Contrast-enhanced ultrasonography; Ductal adenocarcinoma; Pancreatic masses; Pancreatic tumors

Mesh:

Substances:

Year:  2015        PMID: 25796427     DOI: 10.1016/j.ejrad.2015.02.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

1.  In vivo Biodistribution of Radiolabeled Acoustic Protein Nanostructures.

Authors:  Johann Le Floc'h; Aimen Zlitni; Holly A Bilton; Melissa Yin; Arash Farhadi; Nancy R Janzen; Mikhail G Shapiro; John F Valliant; F Stuart Foster
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

Review 2.  Advances in Diagnostic Imaging in Pediatric Gastroenterology.

Authors:  Jonathan Zember; Judyta Loomis; Pranav Vyas; Vahe Badalyan; Narendra Shet
Journal:  Curr Gastroenterol Rep       Date:  2020-03-19

Review 3.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

Review 4.  The role of contrast-enhanced endoscopic ultrasound in pancreatic adenocarcinoma.

Authors:  Adrian Saftoiu; Peter Vilmann; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2016 Nov-Dec       Impact factor: 5.628

Review 5.  Endoscopic ultrasound versus computed tomography in determining the resectability of pancreatic cancer: A diagnostic test accuracy meta-analysis.

Authors:  Muhammad I O Rahman; Brian P H Chan; Parsa M Far; Lawrence Mbuagbaw; Lehana Thabane; Mohammad Yaghoobi
Journal:  Saudi J Gastroenterol       Date:  2020 May-Jun       Impact factor: 2.485

6.  Application of Contrast-Enhanced Ultrasound in the Digestive System.

Authors:  Shen-Yung Wang
Journal:  J Med Ultrasound       Date:  2018-06-12

7.  Clinical use of contrast-enhanced ultrasound beyond the liver: a focus on renal, splenic, and pancreatic applications.

Authors:  Giorgia Tedesco; Alessandro Sarno; Giulio Rizzo; Annamaria Grecchi; Ilaria Testa; Gabriele Giannotti; Mirko D'Onofrio
Journal:  Ultrasonography       Date:  2018-12-30

8.  Unicentric Castleman disease was misdiagnosed as pancreatic mass: A case report.

Authors:  Hong-Yan Zhai; Xin-Yuan Zhu; Gui-Ming Zhou; Li Zhu; Dan-Dan Guo; Hao Zhang
Journal:  World J Clin Cases       Date:  2022-02-06       Impact factor: 1.337

Review 9.  Focal Pancreatic Lesions: Role of Contrast-Enhanced Ultrasonography.

Authors:  Tommaso Vincenzo Bartolotta; Angelo Randazzo; Eleonora Bruno; Pierpaolo Alongi; Adele Taibbi
Journal:  Diagnostics (Basel)       Date:  2021-05-26

10.  Ultrasound imaging features of isolated pancreatic tuberculosis.

Authors:  Yi Dong; Christian Jürgensen; Rajesh Puri; Mirko D'Onofrio; Michael Hocke; Wen-Ping Wang; Nathan Atkinson; Malay Sharma; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2018 Mar-Apr       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.